Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05793034

Predictive Factors for Survival in Aggressive Meningiomas

Analysis of Predictive Factors for Overall and Progression-free Survival After Neurosurgery for Atypical or Anaplastic Meningioma

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
250 (estimated)
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The investigators plan to collect clinical and molecular data, including ICH, PCR, NGS and methylome, from patients operated on for grade 2 or grade 3 meningioma. The purpose of the study is to identify reliable and easy-to-assess predictive factors for recurrence and survival after surgery.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTBiological biomarker assessmentIHC, PCR, NGS, methylome

Timeline

Start date
2021-01-07
Primary completion
2026-01-07
Completion
2027-01-07
First posted
2023-03-31
Last updated
2025-03-13

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT05793034. Inclusion in this directory is not an endorsement.

Predictive Factors for Survival in Aggressive Meningiomas (NCT05793034) · Clinical Trials Directory